All In MedTech

Indication · Neurology & Neurosurgery

ADHD

Devices FDA has cleared or approved since 2000 for adhd, found through the 4 FDA device types (product codes) used for it, plus device trials and research. Also searched as: attention deficit hyperactivity disorder, ADHD.

Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov

Devices

18

Cleared or approved since 2000

PMA and De Novo

3

Higher-risk or first-of-kind devices

Breakthrough devices

1

Authorized through June 30, 2026

Recruiting device trials

32

174 device trials in all

Breakthrough-designated devices

Devices

3 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.

AllPMADe Novo510(k)
  • EndeavorRx

    Akili Interactive Labs, Inc. · De Novo · Digital Therapeutic Software For Attention Deficit Hyperactivity Disorder · newest 2023 · 2 decisions

2 more devices with a free account

Device trials

Device studies on ClinicalTrials.gov for this condition, any status, newest update first.

Open in Trial Radar
  • National Taiwan University HospitalAcademic, hospital or other

    NCT07922018 · 120 participants (planned) · Start Aug 1, 2026 · Primary completion Jul 31, 2027

    Device: Generative artificial intelligence assisted diary platform home-based intervention · For: ADHD - Attention Deficit Disorder With Hyperactivity; ADHD - Combined Type; ADHD - Inattentive Type

    Sites: Hsinchu, Taiwan

173 more trials with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.